➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
Harvard Business School
AstraZeneca
Medtronic
McKesson

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

CEFAZOLIN SODIUM - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for cefazolin sodium and what is the scope of patent protection?

Cefazolin sodium is the generic ingredient in eight branded drugs marketed by Glaxosmithkline, Baxter Hlthcare, B Braun, Abraxis Pharm, Acs Dobfar, Aurobindo Pharma, Bedford, Cephazone Pharma, Dr Reddys, Facta Farma, Fresenius Kabi Usa, Hikma Farmaceutica, Hospira Inc, Qilu, Samson Medcl, Sandoz, Steri Pharma, Teva Pharms, West-ward Pharms Int, Lilly, and Baxter Hlthcare Corp, and is included in thirty-nine NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-seven drug master file entries for cefazolin sodium. Sixteen suppliers are listed for this compound.

Recent Clinical Trials for CEFAZOLIN SODIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of British ColumbiaEarly Phase 1
Aswan University HospitalN/A
Federal University of São PauloPhase 4

See all CEFAZOLIN SODIUM clinical trials

Pharmacology for CEFAZOLIN SODIUM
Medical Subject Heading (MeSH) Categories for CEFAZOLIN SODIUM

US Patents and Regulatory Information for CEFAZOLIN SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Acs Dobfar CEFAZOLIN SODIUM cefazolin sodium INJECTABLE;INJECTION 065303-001 Oct 22, 2008 AP RX No No   Start Trial   Start Trial   Start Trial
Fresenius Kabi Usa CEFAZOLIN SODIUM cefazolin sodium INJECTABLE;INJECTION 064170-001 Mar 18, 1998 DISCN No No   Start Trial   Start Trial   Start Trial
Abraxis Pharm CEFAZOLIN SODIUM cefazolin sodium INJECTABLE;INJECTION 062688-005 Aug 3, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Hospira Inc CEFAZOLIN SODIUM cefazolin sodium INJECTABLE;INJECTION 201654-001 Feb 3, 2016 DISCN No No   Start Trial   Start Trial   Start Trial
Samson Medcl CEFAZOLIN SODIUM cefazolin sodium INJECTABLE;INJECTION 065141-002 Nov 29, 2006 RX No Yes   Start Trial   Start Trial   Start Trial
Baxter Hlthcare ANCEF IN DEXTROSE 5% IN PLASTIC CONTAINER cefazolin sodium INJECTABLE;INJECTION 050566-003 Jun 8, 1983 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
AstraZeneca
Boehringer Ingelheim
Mallinckrodt
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.